PANK1

PF3D7_1420600 (PfPanK1) is a functional pantothenate kinase that catalyzes the first committed step of coenzyme A biosynthesis in Plasmodium and is essential for blood-stage parasite growth (PMID:29614109). Rather than acting as a conventional homodimer, PfPanK1 assembles into a heteromeric complex with PfPanK2 and the multifunctional protein Pf14-3-3I, and this tripartite assembly constitutes a single functional pantothenate kinase — the first example of a heteromeric PanK complex described in nature (PMID:34324601). Recombinant PfPanK1 phosphorylates pantothenate and additionally accepts pantetheine as a primary substrate, indicating that blood-stage CoA biosynthesis can bypass pantothenate (PMID:33768012). Its essentiality and druggability are underscored by resistance-conferring mutations selected under pantothenate-analogue pressure (pantothenol and CJ-15,801), which alter PfPanK activity and impose fitness costs (PMID:29614109), and by natural-product inhibitors identified against the recombinant enzyme (PMID:33768012). Across the life cycle, the requirement is stage-specific: in P. yoelii, PanK1 knockout leaves asexual and sexual blood-stage development intact but severely impairs ookinete, oocyst, and sporozoite formation, establishing an essential role in mosquito-stage transmission (PMID:27644319).

1. 2016 High

   Whether PanK1 is required uniformly across the parasite life cycle was unknown; genetic ablation resolved that its essential contribution is stage-specific rather than global.

   Evidence Gene-deletion knockout in P. yoelii with stage-resolved phenotyping and transcriptional analysis of CoA biosynthesis genes

   PMID:27644319

   Open questions at the time

   • Does not identify the molecular basis of the mosquito-stage requirement
   • Does not address whether the P. falciparum ortholog shows the same stage dependence
   • Enzymatic activity of PyPanK1 not directly measured
2. 2018 High

   Whether Pfpank1 encodes a functional, growth-essential pantothenate kinase in blood-stage P. falciparum was established by drug-resistance genetics linking the gene to PanK activity and fitness.

   Evidence Resistance selection against pantothenate analogues followed by whole-genome sequencing, PanK activity measurement, and fitness assessment in resistant lines

   PMID:29614109

   Open questions at the time

   • Does not resolve how each mutation alters catalysis at the structural level
   • Direct in vitro enzymology of the mutant proteins not shown
3. 2021 High

   The catalytic substrate range of the enzyme was defined, showing PfPanK1 accepts pantetheine in addition to pantothenate and thereby permitting a pantothenate-bypass route to CoA.

   Evidence Recombinant PfPanK1 purification and in vitro kinase assays with pantothenate and pantetheine, plus inhibitor screening

   PMID:33768012

   Open questions at the time

   • Kinetic parameters distinguishing the two substrates in the physiological complex not established
   • Inhibitor mechanism of action not resolved
4. 2021 High

   The quaternary organization of the active enzyme was unknown; co-IP and activity reconstitution revealed a novel heteromeric PanK complex rather than the canonical homodimer.

   Evidence Reciprocal co-immunoprecipitation identifying PfPanK1/PfPanK2/Pf14-3-3I, with enzymatic activity confirmed for the complex

   PMID:34324601

   Open questions at the time

   • Stoichiometry and architecture of the complex not structurally defined
   • Individual catalytic contribution of PfPanK1 versus PfPanK2 within the complex unresolved
   • Regulatory role of Pf14-3-3I not mechanistically dissected
5. 2023 Low

   A possible link between PANK1 and amodiaquine response was raised by sequence and expression changes under drug pressure, but a causal role was not demonstrated.

   Evidence Sequencing and stage-specific qPCR of PANK1 in amodiaquine-resistant P. berghei ANKA, with in silico ligand-binding motif analysis

   PMID:38915420

   Open questions at the time

   • No reverse-genetics validation of the Asn394His mutation in resistance
   • Causal role explicitly unconfirmed by the authors
   • Functional consequence of the differential expression not tested

• How the heteromeric PfPanK1/PfPanK2/Pf14-3-3I complex is structurally organized and regulated, and what molecular process drives the mosquito-stage-specific requirement, remain open.
• No structural model of the heteromeric complex
• Mechanistic basis of stage-specific essentiality unresolved
• Role of Pf14-3-3I in modulating PanK activity uncharacterized